staurosporine has been researched along with hydroxyurea in 12 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 4 (33.33) | 18.2507 |
| 2000's | 2 (16.67) | 29.6817 |
| 2010's | 5 (41.67) | 24.3611 |
| 2020's | 1 (8.33) | 2.80 |
| Authors | Studies |
|---|---|
| García-Mera, X; González-Díaz, H; Prado-Prado, FJ | 1 |
| Afshari, CA; Chen, Y; Dunn, RT; Hamadeh, HK; Kalanzi, J; Kalyanaraman, N; Morgan, RE; van Staden, CJ | 1 |
| Chang, TY; Lee, HY; Lee, NZ; Lee, SB; Liu, CY; Yu, ZY | 1 |
| Birkenhäger, JC; Bos, MP; Buurman, CJ; Pols, HA; Staal, A; van den Bemd, GJ; van Leeuwen, JP | 1 |
| Kumar, NA; Manogaran, PS; Pande, G | 1 |
| Beppu, T; Horinouchi, S; Inagaki, M; Tsujimura, K; Usui, T; Yoshida, M | 1 |
| Hervé, P; Pavy, JJ; Yerly-Motta, V | 1 |
| Mancuso, P; Peters-Golden, M | 1 |
| Feijoo, C; Gilbert, DM; Hall-Jackson, C; Jenkins, D; Leitch, J; Smythe, C; Wu, R | 1 |
| Pardanani, A | 2 |
| Chung, I; Eastman, A; Garner, KM; Montano, R; Parry, D | 1 |
1 review(s) available for staurosporine and hydroxyurea
| Article | Year |
|---|---|
Systemic mastocytosis in adults: 2012 Update on diagnosis, risk stratification, and management.
Topics: Adrenal Cortex Hormones; Adult; Bone Marrow Examination; Cell Lineage; Cladribine; Clinical Trials as Topic; Clone Cells; Disease Management; Disease Progression; Humans; Hydroxyurea; Immunophenotyping; Interferon-alpha; Leukemia, Mast-Cell; Mast Cells; Mastocytosis, Systemic; Mutation, Missense; Organ Specificity; Prognosis; Protein Kinase Inhibitors; Proto-Oncogene Proteins c-kit; Risk Assessment; Staurosporine; Tryptases | 2012 |
11 other study(ies) available for staurosporine and hydroxyurea
| Article | Year |
|---|---|
Multi-target spectral moment QSAR versus ANN for antiparasitic drugs against different parasite species.
Topics: Antiparasitic Agents; Molecular Structure; Neural Networks, Computer; Parasitic Diseases; Quantitative Structure-Activity Relationship; Species Specificity; Thermodynamics | 2010 |
A multifactorial approach to hepatobiliary transporter assessment enables improved therapeutic compound development.
Topics: Animals; ATP Binding Cassette Transporter, Subfamily B; ATP Binding Cassette Transporter, Subfamily B, Member 11; ATP-Binding Cassette Transporters; Biological Transport; Chemical and Drug Induced Liver Injury; Cluster Analysis; Drug-Related Side Effects and Adverse Reactions; Humans; Liver; Male; Multidrug Resistance-Associated Proteins; Pharmacokinetics; Rats; Rats, Sprague-Dawley; Recombinant Proteins; Risk Assessment; Risk Factors; Toxicity Tests | 2013 |
Design, synthesis and biological evaluation of bisindole derivatives as anticancer agents against Tousled-like kinases.
Topics: Antineoplastic Agents; Cell Proliferation; Dose-Response Relationship, Drug; Drug Design; Drug Screening Assays, Antitumor; HEK293 Cells; Humans; Indole Alkaloids; Molecular Structure; Protein Kinase Inhibitors; Protein Serine-Threonine Kinases; Structure-Activity Relationship; Tumor Cells, Cultured | 2022 |
Evidence for the functional involvement of protein kinase C in the action of 1,25-dihydroxyvitamin D3 in bone.
Topics: Alkaloids; Animals; Bone Resorption; Calcitriol; Calcium; Cells, Cultured; Diglycerides; Hydroxyurea; Kinetics; Osteoblasts; Osteocalcin; Protein Kinase C; Rats; Receptors, Calcitriol; Receptors, Steroid; Signal Transduction; Staurosporine; Tetradecanoylphorbol Acetate; Up-Regulation | 1992 |
Flow cytometric study of changes in the intracellular free calcium during the cell cycle.
Topics: Alkaloids; Aniline Compounds; Animals; Benzimidazoles; Calcium; Cell Cycle; Cell Line; DNA; Fibroblasts; Flow Cytometry; Fluorescent Dyes; G1 Phase; Hydroxyurea; Protein Kinase C; Rats; RNA; Staurosporine; Xanthenes | 1996 |
Biochemical differences between staurosporine-induced apoptosis and premature mitosis.
Topics: Animals; Apoptosis; CDC2 Protein Kinase; Cell Cycle; CHO Cells; Chromosomes; Cricetinae; Cricetulus; DNA Replication; Enzyme Activation; Enzyme Inhibitors; Fibroblasts; Histones; Hydroxyurea; Mitosis; Phosphoproteins; Phosphorylation; Protein Processing, Post-Translational; Rats; Staurosporine | 1997 |
Screening of five specific cell cycle inhibitors using a T cell lymphoma cell line synchrony/release assay.
Topics: Aphidicolin; Cell Cycle; Humans; Hydroxyurea; Lymphoma, T-Cell; Mimosine; Nocodazole; Staurosporine; Tumor Cells, Cultured | 1999 |
Modulation of alveolar macrophage phagocytosis by leukotrienes is Fc receptor-mediated and protein kinase C-dependent.
Topics: Acetophenones; Animals; Cell Line; Dose-Response Relationship, Drug; Enzyme Inhibitors; Erythrocytes; Female; Hydroxyurea; Immune Sera; Immunoglobulin G; Klebsiella pneumoniae; Leukotriene Antagonists; Leukotrienes; Macrophages, Alveolar; Microspheres; Naphthalenes; Phagocytosis; Protein Kinase C; Rats; Rats, Wistar; Receptors, Cell Surface; Receptors, Fc; Receptors, Leukotriene B4; Sheep; Staurosporine; Tetradecanoylphorbol Acetate; Tetrazoles | 2000 |
Activation of mammalian Chk1 during DNA replication arrest: a role for Chk1 in the intra-S phase checkpoint monitoring replication origin firing.
Topics: Alkaloids; Animals; Aphidicolin; Ataxia Telangiectasia; Caffeine; Cell Fractionation; Cell Line; Cell Separation; Checkpoint Kinase 1; Checkpoint Kinase 2; DNA Replication; Enzyme Inhibitors; Flow Cytometry; Humans; Hydroxyurea; Immunoblotting; Microscopy, Fluorescence; Nucleic Acid Synthesis Inhibitors; Phosphodiesterase Inhibitors; Protein Kinases; Protein Serine-Threonine Kinases; Radiation, Ionizing; Replication Origin; S Phase; Staurosporine | 2001 |
Systemic mastocytosis in adults: 2011 update on diagnosis, risk stratification, and management.
Topics: Adult; Antineoplastic Agents; Benzamides; Bone Marrow; Cladribine; Dasatinib; Disease-Free Survival; Humans; Hydroxyurea; Imatinib Mesylate; Interferon Type I; Mast Cells; Mastocytosis, Systemic; Piperazines; Point Mutation; Proto-Oncogene Proteins c-kit; Pyrimidines; Recombinant Proteins; Risk; Staurosporine; Thiazoles | 2011 |
Preclinical development of the novel Chk1 inhibitor SCH900776 in combination with DNA-damaging agents and antimetabolites.
Topics: Antimetabolites; Antineoplastic Agents; Blotting, Western; Camptothecin; Cell Cycle Checkpoints; Cell Line; Cell Line, Tumor; Cell Proliferation; Cell Survival; Checkpoint Kinase 1; Cytarabine; Deoxycytidine; DNA Breaks, Double-Stranded; DNA Damage; Dose-Response Relationship, Drug; Drug Screening Assays, Antitumor; Drug Synergism; Flow Cytometry; Gemcitabine; Humans; Hydroxyurea; Irinotecan; Molecular Structure; Phosphorylation; Protein Kinase Inhibitors; Protein Kinases; Pyrazoles; Pyrimidines; Staurosporine | 2012 |